COVID-19 vaccine Archives
Should I get a second bivalent COVID-19 booster?
May. 11, 2023—According to the Centers for Disease Control and Prevention, if you are 65 years and older or have a weakened immune system, then you are eligible to get a second COVID-19 booster vaccine at least four months after your initial bivalent booster. People with weakened immune systems, such as those who have received transplants, should...
One Hundred Oaks COVID-19 vaccination site to close April 7
Mar. 30, 2023—The COVID-19 vaccination site at Vanderbilt Health One Hundred Oaks will close on April 7.
COVID-19 vaccination site at One Hundred Oaks to close April 7
Mar. 23, 2023—The COVID-19 vaccination site at Vanderbilt Health One Hundred Oaks will close on April 7. Since the COVID-19 vaccine became available in late 2020, VUMC has administered 257,000 doses of the vaccine. “We are grateful to all our staff who have made this program a success,” said Patty Wright, MD, professor of Medicine and Chief...
Reminder: COVID-19 bivalent boosters available through Occupational Health Clinic
Dec. 20, 2022—During this busy season, the Occupational Health Clinic (OHC) offers many convenient ways to receive your COVID-19 booster. The bivalent booster vaccine provides better protection against the current strains of COVID-19 and is a great way to keep yourself and others protected. As a reminder, VUMC employees should update their bivalent booster status with OHC...
Bivalent booster vaccine effective in preventing COVID-19 hospitalization in older adults
Dec. 16, 2022—The new bivalent mRNA COVID-19 booster vaccines that began being used in September are beneficial in preventing COVID-19-associated hospitalization in persons 65 and over.
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
Nov. 4, 2022—A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.
COVID antibody research conducted at VUMC lands national award
Aug. 24, 2022—A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.
Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine
Jul. 20, 2022—In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.
Study shows two vaccine doses for mothers eases COVID complications for infants
Jul. 6, 2022—Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.
COVID-19 vaccines for children 6 months through 4 years available
Jun. 22, 2022—Children ages 6 months through age 4 years are now eligible to get the COVID-19 vaccine. Monroe Carell Jr. Children’s Hospital at Vanderbilt will offer vaccines for this age group on Wednesday, Thursday, and Friday, June 22, 23 and 24. Appointments are required and available between 2 p.m. and 5:30 p.m. Saturday, June 25. Appointments are required and available between 8 a.m. and 11:30 a.m.
VUMC research aids approval of COVID-19 vaccine for young children
Jun. 16, 2022—The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday.
Panel considers ways to improve vaccine readiness, restore trust
May. 19, 2022—A recent Ethics Grand Rounds, sponsored by the Vanderbilt Center for Biomedical Ethics and Society, explored potential ways to overcome vaccine readiness and restore trust in health care providers.
